Rennova Health, Inc.
RNVAOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$4305132
P/E Ratio—
52W High$0.0001
52W Low$0.0001
Rennova Health, Inc. (RNVA) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
RNVA · earnings · updated Jun 9, 2026
Latest Earnings
Q4 FY2022Report Date: Dec 31, 2022EPS Actual
$0.05
Revenue
$0.01B
Fiscal Period
Q4 FY2022
FY ends December
Report Date
Dec 31, 2022
After Market Close
RNVA reports quarterly as a OTC-listed Medical - Diagnostics & Research company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$-0.11
Rev. $0.17B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$-0.11
Rev. Est.$0.17B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q4 FY2023 | Nov 14, 2023 | — | — | — | — | — | — |
| ◌ Q3 FY2023 | Aug 15, 2023 | — | — | — | — | — | — |
| ◌ Q2 FY2023 | May 15, 2023 | — | — | — | — | — | — |
| — Q4 FY2022 | Dec 31, 2022 | — | $0.05 | — | $0.01B | — | — |
| — Q4 FY2022 | Nov 14, 2022 | — | -$0.00 | — | $0.00B | — | — |
| — Q3 FY2022 | Aug 15, 2022 | — | -$0.11 | — | $0.00B | — | — |
| — Q1 FY2022 | Mar 31, 2022 | — | -$28.79 | — | $0.00B | — | — |
| — Q4 FY2021 | Dec 31, 2021 | — | -$0.01 | — | $0.00B | — | — |
Q4 FY2023
Nov 14, 2023
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2023
Aug 15, 2023
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2023
May 15, 2023
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2022
Dec 31, 2022
EPS Actual
$0.05
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q4 FY2022
Nov 14, 2022
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2022
Aug 15, 2022
EPS Actual
-$0.11
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2022
Mar 31, 2022
EPS Actual
-$28.79
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2021
Dec 31, 2021
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2023 | $0.00 | — | $0.00 | 0 |
| Q2 FY2023 | $0.00 | — | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2023 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2023 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q4 FY2022 | Dec 31, 2022 | — | $0.00 | $0.00 | +9900.00% |
| — Q4 FY2022 | Nov 14, 2022 | — | $0.00 | $0.00 | +0.00% |
| — Q3 FY2022 | Aug 15, 2022 | — | $0.00 | $0.00 | +0.00% |
| — Q1 FY2022 | Mar 31, 2022 | — | $0.01 | $0.01 | -23.08% |
| — Q4 FY2021 | Dec 31, 2021 | — | $0.00 | $0.00 | +0.00% |
| — Q4 FY2021 | Nov 15, 2021 | — | $0.00 | $0.00 | +0.00% |
| — Q2 FY2021 | Jun 14, 2021 | — | $0.80 | $0.70 | -12.50% |
| — Q1 FY2021 | Mar 31, 2021 | — | $4.70 | $4.30 | -8.51% |
Q4 FY2022+9900.00%
Report Date
Dec 31, 2022
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Q4 FY2022+0.00%
Report Date
Nov 14, 2022
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Q3 FY2022+0.00%
Report Date
Aug 15, 2022
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Q1 FY2022-23.08%
Report Date
Mar 31, 2022
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q4 FY2021+0.00%
Report Date
Dec 31, 2021
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Q4 FY2021+0.00%
Report Date
Nov 15, 2021
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Q2 FY2021-12.50%
Report Date
Jun 14, 2021
EPS Beat/Miss
—
Price Before
$0.80
Price After
$0.70
Q1 FY2021-8.51%
Report Date
Mar 31, 2021
EPS Beat/Miss
—
Price Before
$4.70
Price After
$4.30
Beat Rate0 / 8 quarters
Largest Move+9900.00% (Q4 FY2022)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: RNVA ends December
Rennova Health, Inc. (RNVA) most recently reported earnings on December 31, 2022 for Q4 FY2022, posting EPS of $0.05 (in line with the analyst consensus of —). The next RNVA earnings date is expected around September 1, 2026.
Each quarter, investors track RNVA earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. RNVA revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
RNVA's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
RNVA earnings · 4 questionsRennova Health, Inc.'s next earnings report is expected around September 1, 2026. RNVA typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; RNVA historically reports after market close (AMC).
RNVA earnings datewhen is RNVA earningsRNVA next earnings datewhen does RNVA report earningsRNVA earnings calendar
▸ Source: FMP · Rennova Health, Inc. SEC filings · US GAAP · Rennova Health, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026